3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Lymphoid
1
Hematologic Diseases
1
Interventions
venetoclax
4
fludarabine phosphate
3
ibrutinib
2
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
pembrolizumab
1
obinutuzumab
1
ixazomib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
auricularum
1
acalabrutinib
1
Tacrolimus
1
RG7388
1
Nivolumab
1
Melphalan
1
Etoposide
1
Dexamethasone
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chromosome 17 deletion
×
pirtobrutinib
×
Clear all
No trials found.